Technical notes

This section includes Technical notes which aim to give an overview how we conduct our research in selected areas.

We aim to continuously update this section in order to present a full scope of services offered by Selvita.

Technical notes
In vitro Metabolism

Drug metabolism includes a wide range of biochemical processes, which finally lead to either drug inactivation or drug transformation, which facilitates the elimination of xenobiotics from the human body.

Drugs can be metabolized in different organs, such as intestines, kidneys, spleen, lungs, however, for the large majority of pharmaceutical drug metabolism occurs in the liver.
Therefore, assessment of in vitro intrinsic clearance or identification of metabolites formed is crucial at an early stage of the drug discovery process.

In vitro…

Find out more
Development of an in vitro assay of neurodegeneration using human pluripotent stem cell–derived neurons

Human induced pluripotent stem cells (hiPSC) are obtained by genetically reprogramming somatic cells from human tissues, after which these cells can be further differentiated virtually into any cell types. hiPSC are derived from normal adults or from diseased patients and carry protein mutations that are able to compromise the cell physiology.

As consequence, hiPSC-derived cells reveal a high potential for studying pathophysiological processes in basically all pathological areas including CNS, PNS, peripheral tissues (cardiac, hepatic, pulmonary, muscular, vessel, blood, etc.)…

Find out more
Flow Chemistry Methodology


Flow chemistry is a technology for organic synthesis where, using an apparatus of microfluidics, reactants are brought together within small reaction volumes and reaction products are collected as part of an ongoing flow process.  In such a flow process the reaction is initiated and continues with a constant fresh supply of reactants until such time when reagents are exhausted or the reaction is stopped by the chemist or operator. 


Flow chemistry offers an interesting…

Find out more
Recombinant Stable Cell Line Development

The generation of cell lines overexpressing particular proteins on which drug discovery programs are often based, is necessary for assay development in screening campaigns using initial target-based identification of hit compounds. Recombinant stable cell lines are also used for toxicity studies and general in vitro testing.

Methods to be used and the cell background for the generation of a cell line could depend on several factors: i) the complexity of protein (e.g. dimensions, carrying antibiotic resistance, presence of tags etc.)…

Find out more
Protein aggregation assays at Selvita

Proteins typically undergo a proper folding via intracellular chaperone machinery. Folding confers to proteins the spatial characteristics that define their role in the cells, however the folding process might not always work properly. For intrinsic changes of protein characteristics (e.g. mutations and/or improper elongation, PTMs etc.) or for defective chaperone activity, proteins can assume a wrong conformation. In this case complex intracellular degradative systems are able to recognize the misfolded proteins and provide their degradation and clearance, through the ubiquitin-proteasome…

Find out more

Contact form

    According to the Regulation 2016/679 of the European Parliament and the Council (EU) of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation; "GDPR"), we hereby inform you that Your personal data will be processed by Selvita S.A. and the companies operating within the Selvita Capital Group in order to present You the Selvita Newsletter. Your personal data are processed in connection with Newsletter subscription and in order to keep You informed about all events taking place in Selvita Capital Group.

    We guarantee full transparency of the data processing and compliance with all the rights referred to in GDPR, i.e. the right of access, rectification and deletion of data, limiting data processing, the right to transfer, the right to raise objection against processing. Notwithstanding the above, You have the right to submit a complaint to the supervisory authority. Your personal data are not being subject to automated decision-making, including profiling. Your personal data are provided on the voluntary basis, however please be informed that lack of consent results in inability to provide You the Newsletter by Selvita Group. Your data will be processed for the duration of your consent, unless your consent to the processing of your personal data is revoked. Your consent may be withdrawn at any time by sending a request to the e-mail address:

    For more information on how Selvita handles personal data please visit: Privacy Policy. I hereby express my consent to the processing of my personal data by Selvita S.A. with registered office in Cracow 30-348, Bobrzyńskiego 14 and its affiliated companies in order to receive the Newsletter, information about events organized by the Selvita Capital Group and other information regarding Selvita Group activity in accordance with the Regulation 2016/679 of the European Parliament and the Council (EU) of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation).